MGRX
Mangoceuticals·NASDAQ
--
--(--)
--
--(--)
7.45 / 10
Outperform
Analyst sentiment is unavailable (ana_eval -1). Fund‑flow sentiment is strong, scoring 7.45/10, with positive inflows across most size categories except large investors. The bullish capital flow partially offsets weak fundamentals and technicals, but lack of analyst backing adds uncertainty.
Fund Flow Rating
What is the market sentiment for MGRX?
- MGRX holds a Neutral analyst rating, with 0% of experts assigning a Hold grade. Factoring in net Inflows from order flow data, the comprehensive Sentiment Score stands at 7.45/10 (Outperform).
